Clinical data | |
---|---|
Other names | Dimeditiapramine; Ro 11-1781 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.054.992 |
Chemical and physical data | |
Formula | C26H37NO8S2 |
Molar mass | 555.70 g·mol−1 |
3D model ( JSmol) | |
|
Tiapamil ( INN; also known as dimeditiapramine) is a calcium antagonist or calcium channel blocker. [1] [2] It is an experimental drug that has never been marketed. [3]
Tiapamil has been described as an antianginal agent. It exhibits properties of anti-arrhythmic medications. These are medications that are used to treat unusually fast or irregular heartbeats. Examples of arrhytmthic conditions include atrial fibrillation, atrial flutter, and super-ventricular tachycardia. [4] Upon research, the drug shows promising effects on treatment of these condition. Research seeks to create a treatment with tiapamil in order to mitigate the side effects of the more commonly prescribed calcium antagonist and anti-hypertensive verapamil. The two drugs have similar properties; however, tiapamil appears to treat arrhythmic conditions without many of the hypotensive, negative inotropic, and negative chronotropic side effects. Tiapamil is a calcium channel blocker that acts on the slow calcium channels. It can treat ventricular arrhythmias to a higher degree than traditional calcium antagonists.[ medical citation needed]
Clinical data | |
---|---|
Other names | Dimeditiapramine; Ro 11-1781 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.054.992 |
Chemical and physical data | |
Formula | C26H37NO8S2 |
Molar mass | 555.70 g·mol−1 |
3D model ( JSmol) | |
|
Tiapamil ( INN; also known as dimeditiapramine) is a calcium antagonist or calcium channel blocker. [1] [2] It is an experimental drug that has never been marketed. [3]
Tiapamil has been described as an antianginal agent. It exhibits properties of anti-arrhythmic medications. These are medications that are used to treat unusually fast or irregular heartbeats. Examples of arrhytmthic conditions include atrial fibrillation, atrial flutter, and super-ventricular tachycardia. [4] Upon research, the drug shows promising effects on treatment of these condition. Research seeks to create a treatment with tiapamil in order to mitigate the side effects of the more commonly prescribed calcium antagonist and anti-hypertensive verapamil. The two drugs have similar properties; however, tiapamil appears to treat arrhythmic conditions without many of the hypotensive, negative inotropic, and negative chronotropic side effects. Tiapamil is a calcium channel blocker that acts on the slow calcium channels. It can treat ventricular arrhythmias to a higher degree than traditional calcium antagonists.[ medical citation needed]